Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Assessment of Efficacy and Safety of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years
Atsuyuki Watanabe, Ryoma Kani, Masao Iwagami, et al.
JAMA Pediatrics (2023) Vol. 177, Iss. 4, pp. 384-384
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

The Immunogenicity of Coxsackievirus A6 (D3a Sub‐Genotype) Virus‐Like Particle and mRNA Vaccines
Huanhuan Lu, Jinbo Xiao, Jingdong Song, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 2
Closed Access | Times Cited: 1
COVID-19 Vaccination and Incidence of Pediatric SARS-CoV-2 Infection and Hospitalization
Jennifer R. Head, Philip A. Collender, Tomás M. León, et al.
JAMA Network Open (2024) Vol. 7, Iss. 4, pp. e247822-e247822
Open Access | Times Cited: 12
Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England
Emma Copland, Martina Patone, Defne Saatci, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Vaccination against COVID-19 — risks and benefits in children
Alasdair Munro, Christine E. Jones, Saul N. Faust
European Journal of Pediatrics (2024) Vol. 183, Iss. 3, pp. 1107-1112
Open Access | Times Cited: 9
Liquid Chromatography Methods for Analysis of mRNA Poly(A) Tail Length and Heterogeneity
Martin Gilár, Catalin E. Doneanu, Maissa M. Gaye
Analytical Chemistry (2023) Vol. 95, Iss. 38, pp. 14308-14316
Open Access | Times Cited: 16
Evidence linking COVID-19 and the health/well-being of children and adolescents: an umbrella review
Chengchen Duan, Liu Liu, Tianyi Wang, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Systematic Review of COVID-19 and COVID-19 mRNA Vaccine Myocarditis in Athletes: Incidence, Diagnosis, Prognosis, and Return-to-Play Principles
O. Mahneva, Tamara R. Fakhoury, Sukhwinder Singh Hanspal, et al.
Clinical Journal of Sport Medicine (2025)
Closed Access
Preferences for and drivers of adult vaccination clinic site selection: A cross-sectional study in 30 provinces in China
Yuxi Liu, Yanlin Cao, Yugang Li, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Navigating the shots: Parental willingness to immunize their children with COVID-19 vaccines in Saudi Arabia explored through a systematic review and meta-analysis
Moustafa Abdelaal Hegazi, Mohamed Hesham Sayed, Nadeem Shafique Butt, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0317983-e0317983
Open Access
Editorial: Building public confidence in innovative mRNA vaccines
Jia Hu, Kenneth Rabin, Cora Constantinescu, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Multisystem Inflammatory Syndrome in Children: A Comprehensive Review Over the Past Five Years
Olivia Shyong, Nora AlFakhri, Sara V. Bates, et al.
Journal of Intensive Care Medicine (2025)
Closed Access
The global COVID-19 vaccine surplus: tackling expiring stockpiles
Nguyen Khoi Quan, Nguyen Le My Anh, Andrew W. Taylor‐Robinson
Infectious Diseases of Poverty (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis
Camila Aparicio, Zachary Willis, Mari Nakamura, et al.
Journal of the Pediatric Infectious Diseases Society (2024) Vol. 13, Iss. 7, pp. 352-362
Open Access | Times Cited: 4
The effect of perceived social support and health literacy on parental COVID-19 vaccine hesitation in preschool children: a cross-sectional study
Jiayue Chen, Quqing Wang, Nan Jiang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Interim safety and immunogenicity of COVID-19 omicron BA.1 variant-containing vaccine in children in the USA: an open-label non-randomised phase 3 trial
Avika Dixit, Richard L. Bennett, Kashif Ali, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 7, pp. 687-697
Open Access | Times Cited: 3
Real-world effectiveness of the heterologous SOBERANA-02 and SOBERANA-Plus vaccine scheme in 2–11 years-old children during the SARS-CoV-2 Omicron wave in Cuba: a longitudinal case-population study
María Eugenia Toledo-Romaní, Carmen Valenzuela‐Silva, Minerva Montero-Díaz, et al.
The Lancet Regional Health - Americas (2024) Vol. 34, pp. 100750-100750
Open Access | Times Cited: 3
Booster vaccination using bivalent DS-5670a/b is safe and immunogenic against SARS-CoV-2 variants in children aged 5–11 years: a phase 2/3, randomized, active-controlled study
Rino Suzuki, Miharu Suda, Katsuyasu Ishida, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
COVID-19 Vaccines in Young Children—Reassuring Evidence for Parents
Paul A. Offit
JAMA Pediatrics (2023) Vol. 177, Iss. 4, pp. 333-333
Open Access | Times Cited: 6
Emerging and re-emerging pediatric viral diseases: a continuing global challenge
Seth A. Hoffman, Yvonne Maldonado
Pediatric Research (2023) Vol. 95, Iss. 2, pp. 480-487
Open Access | Times Cited: 6
Considerations for vaccinating children against COVID-19
John Hart, Darren Suryawijaya Ong, Kulkanya Chokephaibulkit, et al.
BMJ Paediatrics Open (2023) Vol. 7, Iss. 1, pp. e001964-e001964
Open Access | Times Cited: 5
Association of Prior COVID-19 Vaccination With SARS-CoV-2 Infection and Death in Children and Young Persons During the Omicron Variant Period in Brazil
Eduardo A. Oliveira, Maria Christina L. Oliveira, Ana Cristina Simões e Silva, et al.
JAMA Pediatrics (2023) Vol. 177, Iss. 10, pp. 1100-1100
Open Access | Times Cited: 5
Age dependent discrepancy between SARS-CoV-2 anti-nucleoprotein antibody and anti-RBD spike protein antibody in children reflects vaccine coverage
Yasuhito Fujii, Hidetoshi Ishigaki, Isao Miyairi, et al.
Journal of Infection and Chemotherapy (2024) Vol. 30, Iss. 7, pp. 646-650
Closed Access | Times Cited: 1
The importance of falsification endpoints in observational studies of vaccination to prevent severe disease: A critique of a harm–benefit analysis of BNT162b2 vaccination of 5- to 11-year-olds
Tracy Beth Høeg, Alyson Haslam, Vinay Prasad
Epidemiology and Infection (2024) Vol. 152
Open Access | Times Cited: 1
Effectiveness of BNT162b2 COVID-19 primary series vaccination in children aged 5–17 years in the United States: a cohort study
Rachel P. Ogilvie, J. Bradley Layton, Patricia C. Lloyd, et al.
BMC Pediatrics (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
COVID-19 Vaccine Hesitancy in Caregivers of Hospitalized Children From 2020 Through 2023
Marisa Orbea, Michelle A. Lopez, Xiaofan Huang, et al.
Hospital Pediatrics (2024) Vol. 14, Iss. 9, pp. 701-713
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top